Specifically, low adherence to treatment in PKU subjects, allowing for high Phe concentrations maintained over time, can not only cause neurological alterations in executive function and behavior, as already described in the literature, but can also affect insulin regulation, decreasing glucose utilization, and facilitating the development of insulin resistance. The gene discussed is INS; the disease is phenylketonuria.